Back
Enovis Corp. 10K Form
Sell
32
ENOV
Enovis Corp.
Last Price:
$27.97
Seasonality Move:
3.89%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ENOV News And Ratings
See the #1 stock for the next 7 days that we like better than ENOV
ENOV Financial Statistics
Sales & Book Value
| Annual Sales: | $2.1B |
|---|---|
| Cash Flow: | $29.1M |
| Price / Cash Flow: | 72.98 |
| Annual Sales: | $35.33 |
| Price / Book: | 0.83 |
Profitability
| EPS (TTM): | -24.20670 |
|---|---|
| Net Income (TTM): | $-1.4B |
| Gross Margin: | $1B |
| Return on Equity: | -52.07% |
| Return on Assets: | -27.78% |
Enovis Corp. Earnings Forecast
Key Enovis Corp. Financial Ratios
-
The Gross Profit Margin over the past 21 years for ENOV is 48.70%.
-
The Selling, General & Administrative Expenses for ENOV have been equal to 48.74% of Gross Profit Margin.
-
The Research & Development expenses have been 4.33% of Revenue.
-
The Net Earning history of ENOV is -39.26% of Total Revenues.
-
Per Share Earnings over the last 21 years have been positive in 9 years.
Enovis Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | ENOV |
| Website: | enovis.com |
Debt
| Debt-to-Equity Ratio: | 0.71 |
|---|---|
| Current Ratio: | 2.22 |
| Quick Ratio: | 0.86 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 8.5 |
ENOV Technical Analysis vs Fundamental Analysis
Sell
32
Enovis Corp. (ENOV)
is a Sell
Is Enovis Corp. a Buy or a Sell?
-
Enovis Corp. stock is rated a SellThe current Enovis Corp. [ENOV] share price is $29.28. The Score for ENOV is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.